Phreesia (PHR)
(Delayed Data from NYSE)
$20.61 USD
+0.15 (0.73%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $20.58 -0.03 (-0.15%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth C Momentum B VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
PHR 20.61 +0.15(0.73%)
Will PHR be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for PHR based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for PHR
Looking for Stocks with Positive Earnings Momentum? Check Out These 2 Medical Names
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
PHR: What are Zacks experts saying now?
Zacks Private Portfolio Services
Stock Market News for Mar 18, 2024
Phreesia (PHR) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
Phreesia (PHR) Reports Q4 Loss, Tops Revenue Estimates
Other News for PHR
Baird reviews short interest in the vertical software space
Phreesia (NYSE:PHR): A Value Play in Healthcare Tech
Phreesia (PHR) Shares Cross Below 200 DMA
Purpose Investments Inc. Announces April 2024 Distributions
Phreesia management to meet with KeyBanc